(VIANEWS) – Shares of Novavax (NASDAQ: NVAX) fell 5.68% to $79.84 at 15:30 EST on Tuesday, after five successive sessions in a row of losses. NASDAQ is jumping 0.63% to $13,855.10, following the last session’s upward trend. This seems, as yet, a somewhat bullish trend exchanging session today.
Novavax’s last close was $79.47, 76.04% under its 52-week high of $331.68.
Today’s last reported volume for Novavax is 6422061 which is 4.4% above its average volume of 6151232.
The company’s growth estimates for the ongoing quarter is a negative 21.8% and positive 213.7% for the next.
Year-on-year quarterly revenue growth grew by 13.9%, now sitting on 1.2B for the twelve trailing months.
Novavax’s last week, last month’s, and last quarter’s current intraday variation average was a negative 5.52%, a negative 3.14%, and a positive 5.15%, respectively.
Novavax’s highest amplitude of average volatility was 5.52% (last week), 4.26% (last month), and 5.15% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Novavax’s stock is considered to be overbought (>=80).
Novavax’s Stock Yearly Top and Bottom Value
Novavax’s stock is valued at $79.84 at 15:30 EST, way under its 52-week low of $107.08.
Novavax’s Moving Average
Novavax’s worth is way under its 50-day moving average of $170.98 and way below its 200-day moving average of $193.54.
More news about Novavax (NVAX).